114 related articles for article (PubMed ID: 15868711)
1. [Study on the diagnosis of prostatic cancer by detecting methylated GSTP1 promotor region from the urinary samples].
Kato T
Hokkaido Igaku Zasshi; 2005 Mar; 80(2):251-61. PubMed ID: 15868711
[No Abstract] [Full Text] [Related]
2. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG
Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
[TBL] [Abstract][Full Text] [Related]
5. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
Chu DC; Chuang CK; Fu JB; Huang HS; Tseng CP; Sun CF
J Urol; 2002 Apr; 167(4):1854-8. PubMed ID: 11912447
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G
Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
[TBL] [Abstract][Full Text] [Related]
7. Methylation-specific PCR for detection of neoplastic DNA in biopsy washings.
Goessl C; Müller M; Heicappell R; Krause H; Schostak M; Straub B; Miller K
J Pathol; 2002 Mar; 196(3):331-4. PubMed ID: 11857497
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
[TBL] [Abstract][Full Text] [Related]
9. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
Vidanes GM; Paton V; Wallen E; Peehl DM; Navone N; Brooks JD
Prostate; 2002 Jun; 51(4):225-30. PubMed ID: 11987150
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
[TBL] [Abstract][Full Text] [Related]
11. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
Singal R; Ferdinand L; Reis IM; Schlesselman JJ
Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
[TBL] [Abstract][Full Text] [Related]
12. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
Harden SV; Guo Z; Epstein JI; Sidransky D
J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
[TBL] [Abstract][Full Text] [Related]
13. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
14. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM
Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725
[TBL] [Abstract][Full Text] [Related]
15. Gene promoter methylation in prostate tumor-associated stromal cells.
Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
[TBL] [Abstract][Full Text] [Related]
16. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
Rogers CG; Gonzalgo ML; Yan G; Bastian PJ; Chan DY; Nelson WG; Pavlovich CP
J Urol; 2006 Nov; 176(5):2280-4. PubMed ID: 17070312
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
Jerónimo C; Usadel H; Henrique R; Oliveira J; Lopes C; Nelson WG; Sidransky D
J Natl Cancer Inst; 2001 Nov; 93(22):1747-52. PubMed ID: 11717336
[TBL] [Abstract][Full Text] [Related]
19. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
